Related Experiment Video
Updated: Jun 5, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
Effects of single nucleotide changes on the binding and activity of RNA aptamers to human papillomavirus 16 E7
Clare Nicol1, David H J Bunka, G Eric Blair
1Institute of Molecular and Cellular Biology, Faculty of Biological Sciences and Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, United Kingdom.
Abstract:
A virally-encoded oncoprotein (E7 from human papillomavirus 16, involved in the initiation of cell transformation) was the target for RNA aptamer development by the process of systematic evolution of ligands by exponential enrichment (SELEX). A number of aptamers were identified, one of which was shown to inhibit the interaction between E7 and its major binding partner, pRb. Aptamers with very similar sequences (more than 92% similarity in the random regions) did not share this activity. This study demonstrates the potential of aptamers to be highly specific, with small differences in aptamer sequence having profound effects on function.
Insights
Researchers developed RNA aptamers targeting the human papillomavirus 16 E7 oncoprotein. One aptamer inhibited E7
Area of Science:
- Molecular Biology
- Virology
- Biotechnology
Background:
- Human papillomavirus 16 (HPV16) oncoprotein E7 is crucial for cell transformation.
- Targeting viral oncoproteins is a strategy for antiviral therapies.
Purpose of the Study:
- To develop RNA aptamers against the HPV16 E7 oncoprotein.
- To investigate the specificity and functional activity of these aptamers.
Main Methods:
- Systematic Evolution of Ligands by Exponential Enrichment (SELEX) was used for aptamer development.
- Functional assays were performed to assess aptamer inhibition of E7-pRb interaction.
Main Results:
- Several RNA aptamers targeting HPV16 E7 were identified.
- One aptamer demonstrated significant inhibition of the E7-pRb binding interaction.
- Aptamers with >92% sequence similarity in random regions showed varied functional activity, highlighting specificity.
Conclusions:
- RNA aptamers can be specifically developed to target viral oncoproteins like HPV16 E7.
- Subtle sequence variations in aptamers can lead to significant differences in functional activity.
- Aptamers show potential as specific inhibitors of viral oncoprotein interactions.
Related Concept Videos
Initiation of Translation
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
Leaky Scanning
Viral Mutations
RNA Editing

